微导管乙化和PERK激活促进了素诱导的线粒体积和细胞死亡
Seongeun Song1, Panseon Ko1, Seula Keum1
1Department of Life Science, Chung-Ang University, Seoul, 06974, Republic of Korea.
Cellular and molecular life sciences : CMLS
|December 31, 2024
概括
埃里布林通过增加微管乙化来触发细胞死亡,从而增强了向线粒体的运输. 这种机制涉及蛋白质激酶RNA类似ER激酶 (PERK),提供了在癌症治疗中克服埃里布林耐药性的策略.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 像埃里布林这样的微管子向剂在癌症治疗中至关重要.
- 药物耐药性,特别是对埃里布林的耐药性,限制了治疗的有效性.
- 了解新的细胞死亡机制是克服抗性的关键.
研究的目的:
- 定义一种由埃里布林向微管所诱导的新型细胞死亡机制.
- 调查微管子乙化在埃里布林敏感性和耐药性的作用.
- 通过这种新的机制探索克服埃里布林耐药性的策略.
主要方法:
- 用埃里布林治疗乳腺癌细胞 (耐药和非耐药)
- 在ATAT1 (α-tubulin N-乙酸转移酶1) 的基因沉默中.
- 微管乙化,Ca2+运输,细胞染色体c释放和转录组的分析.
- 微管乙化和PERK信号的药理学调制.
主要成果:
- 埃里布林在非耐药细胞中增加了微管化和细胞死亡.
- 抗埃里布林细胞显示微管乙烯化减少和PERK活性下调.
- 在ATAT1沉默诱导的埃里布林耐药性.
- 埃里布林诱导的乙化促进了从ER到线粒体的Ca2+运输,导致细胞死亡.
- 使用HDAC6抑制剂和PERK激活剂的联合治疗克服了埃里布林耐药性.
结论:
- 通过ER-线粒体Ca2+过载,由PERK信号传递介导,由素诱导的微管化触发细胞死亡.
- 微管乙化和PERK活性的下调有助于埃里布林耐药性.
- 向微管乙化和PERK信号传递是一个有希望的战略,以克服埃里布林耐药性.
相关概念视频
Destabilization of Microtubules
2.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.5K
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K


